Bellevue Group’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.6M | Hold |
4,094,458
| – | – | 0.59% | 44 |
|
|
2025
Q1 | $33.1M | Hold |
4,094,458
| – | – | 0.74% | 31 |
|
|
2024
Q4 | $50.6M | Hold |
4,094,458
| – | – | 0.97% | 25 |
|
|
2024
Q3 | $33.6M | Hold |
4,094,458
| – | – | 0.54% | 55 |
|
|
2024
Q2 | $20.4M | Hold |
4,094,458
| – | – | 0.33% | 71 |
|
|
2024
Q1 | $25.3M | Sell |
4,094,458
-400,000
| -9% | -$2.47M | 0.39% | 72 |
|
|
2023
Q4 | $22.7M | Hold |
4,494,458
| – | – | 0.35% | 72 |
|
|
2023
Q3 | $25.8M | Hold |
4,494,458
| – | – | 0.42% | 68 |
|
|
2023
Q2 | $16.4M | Hold |
4,494,458
| – | – | 0.23% | 84 |
|
|
2023
Q1 | $19.5M | Hold |
4,494,458
| – | – | 0.28% | 82 |
|
|
2022
Q4 | $31.5M | Hold |
4,494,458
| – | – | 0.42% | 67 |
|
|
2022
Q3 | $16.2M | Hold |
4,494,458
| – | – | 0.23% | 90 |
|
|
2022
Q2 | $14.6M | Sell |
4,494,458
-68,400
| -1% | -$222K | 0.21% | 97 |
|
|
2022
Q1 | $9.13M | Sell |
4,562,858
-40,000
| -0.9% | -$80K | 0.11% | 107 |
|
|
2021
Q4 | $14.5M | Buy |
4,602,858
+2,000,000
| +77% | +$6.28M | 0.15% | 107 |
|
|
2021
Q3 | $12.8M | Hold |
2,602,858
| – | – | 0.13% | 109 |
|
|
2021
Q2 | $17.3M | Hold |
2,602,858
| – | – | 0.17% | 110 |
|
|
2021
Q1 | $14.6M | Hold |
2,602,858
| – | – | 0.15% | 111 |
|
|
2020
Q4 | $20.5M | Hold |
2,602,858
| – | – | 0.23% | 100 |
|
|
2020
Q3 | $22.1M | Hold |
2,602,858
| – | – | 0.31% | 83 |
|
|
2020
Q2 | $27.1M | Hold |
2,602,858
| – | – | 0.38% | 65 |
|
|
2020
Q1 | $24.4M | Buy |
2,602,858
+200,000
| +8% | +$1.87M | 0.47% | 58 |
|
|
2019
Q4 | $19.3M | Buy |
2,402,858
+850,000
| +55% | +$6.81M | 0.31% | 62 |
|
|
2019
Q3 | $31.9M | Buy |
1,552,858
+37,856
| +2% | +$777K | 0.59% | 44 |
|
|
2019
Q2 | $39.5M | Buy |
+1,515,002
| New | +$39.5M | 0.67% | 37 |
|